| Literature DB >> 35848116 |
Magalie Dosset1, Maurizio Zanetti1.
Abstract
Disulfiram, a drug prescribed for the treatment of alcohol use disorders for more than 60 years, has recently been repurposed for cancer treatment. New work in The EMBO Journal now describes a disulfiram role in immunotherapy of cancer, involving direct binding to Lck to mediate activation of tumor-infiltrating T cells.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35848116 PMCID: PMC9379543 DOI: 10.15252/embj.2022111862
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 14.012